Melitracen hydrochloride
Code | Size | Price |
---|
TAR-T4274-10mg | 10mg | £104.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4274-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4274-25mg | 25mg | £122.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4274-50mg | 50mg | £144.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4274-100mg | 100mg | £166.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T4274-200mg | 200mg | £213.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Melitracen Hydrochloride, an antidepressant, is used as potential dopamine D1/2 receptor antagonist to treat depression.
CAS:
10563-70-9
Formula:
C21H26ClN
Molecular Weight:
327.9
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.9982
SMILES:
Cl.CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc12
Target:
Dopamine Receptor; 5-HT Receptor
References
Pacher P,etal.Current trends in the development of new antidepressants.Curr Med Chem. 2001 Feb;8(2):89-100.
Eap CB,etal.Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.Ther Drug Monit. 2004 Apr;26(2):152-5.
Kent JM.SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.Lancet. 2000 Mar 11;355(9207):911-8.
Titier K,etal.High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose.Ther Drug Monit. 2003 Oct;25(5):581-7.